Skip to main content
OpenTrials

Clinical trial condition

Disease Attributes

Explore clinical trials studying Disease Attributes. Study availability and eligibility vary by location and protocol.

21,768 public trials 3,157 recruiting studies
Refine in advanced search Browse all conditions

Disease Attributes trial results

Recruiting

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

NCT03418038

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +27 more
Locations
  • Mayo Clinic Health Systems-Mankato Mankato, Minnesota, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Mayo Clinic Health System-Eau Claire Clinic Eau Claire, Wisconsin, United States
  • Mayo Clinic Health System-Franciscan Healthcare La Crosse, Wisconsin, United States
View Trial Details
Recruiting

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

NCT03328078

Conditions
Disease Attributes, Hematologic Diseases, Hematologic Neoplasms, +17 more
Locations
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Providence St. John's Health Center Santa Monica, California, United States
View all 45 locations
View Trial Details
Recruiting

PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

NCT05313165

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +11 more
Locations
  • University of California, San Diego Health La Jolla, California, United States
  • Stanford University School of Medicine Palo Alto, California, United States
  • UCSF San Francisco, California, United States
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Torrance, California, United States
View all 30 locations
View Trial Details
Recruiting

Combination of TATE and PD-1 Inhibitor in Liver Cancer

NCT03259867

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +18 more
Locations
  • University of California, Irvine Orange, California, United States
  • University of Oklahoma Health Science Center Oklahoma City, Oklahoma, United States
  • Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Recruiting

Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial

NCT06510699

Conditions
Bacterial Infections and Mycoses, Blood Cancer, Communicable Diseases, +13 more
Locations
  • Fred Hutchinson Cancer Centre Seattle, Washington, United States
  • Sydney Children's Hospital Network Sydney, New South Wales, Australia
  • Westmead Hospital Sydney, New South Wales, Australia
  • Royal Brisbane & Women's Hospital Brisbane, Queensland, Australia
View Trial Details
Recruiting

Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines

NCT07415551

Conditions
Allergic Diseases, Chronic Disease, Chronic Spontaneous Urticaria (CSU), +11 more
Locations
  • Diagnostic & Consultative Centre Ascendent EOOD Sofia, Bulgaria
  • UMHAT "Aleksandrovska" Sofia, Bulgaria
  • Medical Center Hera EOOD Sofia, Bulgaria
  • UMHATEM "N. I. Pirogov" Sofia, Bulgaria
View all 30 locations
View Trial Details
Recruiting

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

NCT04329728

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +22 more
Locations
  • City of Hope Duarte, California, United States
  • Los Angeles Cancer Network Los Angeles, California, United States
  • UCLA Medical Center of Hematology/Oncology Los Angeles, California, United States
  • Innovative Clinical Research Institute Whittier, California, United States
View Trial Details

Related conditions